This inventor holds 1 USPTO granted patent. Top assignee: St. Jude Children's Research Hospital. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Innovations by Jing Chen: Pioneering Oligonucleotides for Therapeutic Applications
Introduction
Jing Chen, an innovative inventor based in Morrisville, NC, has made significant strides in the field of biotechnology. With an impressive patent portfolio, her work primarily revolves around therapeutic applications that aim to protect normal tissues from various stressors, including chemical and radiation exposure.
Latest Patents
Chen holds one notable patent titled "Oligonucleotides which inhibit p53 induction in response to cellular stress." This patent describes novel oligonucleotides that include the p53 5'-UTR sequence TCCCTGG (SEQ ID NO: 1) or its complementary p53 3'-UTR sequence CCAGGGA (SEQ ID NO: 2). The invention finds potential applications in multiple therapeutic areas, such as minimizing tissue damage in hypoxia-reperfusion injury, providing protection against neurodegenerative disorders, combating oxidative stress, and preserving tissues and organs for transplantation.
Career Highlights
Jing Chen is currently associated with St. Jude Children's Research Hospital, a leading institute dedicated to treating and curing pediatric catastrophic diseases. Her role at this respected institution emphasizes her commitment to advancing medical research and improving patient outcomes.
Collaborations
Throughout her career, Chen has had the privilege of collaborating with esteemed colleagues, including Michael B. Kastan. These professional associations have further enriched her research and led to groundbreaking advancements in the field of cellular stress response and therapeutic innovations.
Conclusion
Jing Chen's contributions to the realm of biotechnology, underscored by her innovative patent on oligonucleotides, exemplify her dedication to enhancing therapeutic strategies. Her work not only reflects her expertise but also her unwavering commitment to safeguarding human health. As research continues to evolve, Chen’s inventions may pave the way for novel treatments that address critical medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile